A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Clinical trial NCT02311413 · COMPLETED

Trial details

NCT number: NCT02311413
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cat Allergy Cat Hypersensitivity

Start date: 2015-03-09
Primary completion: 2018-07-18
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.